Core Insights - OneMedNet Corporation achieved record bookings of $2.79 million in 2025, exceeding 2024 bookings by more than four times, indicating strong enterprise demand and a shift towards a recurring subscription model [1][7]. Booking Highlights - Total bookings reached $2.79 million in contract value for 2025, which is 4.1 times higher than the previous fiscal year [7]. - The company is experiencing larger deal sizes due to the expansion of average contract value driven by enterprise-scale AI models and life sciences engagements [7]. - There is a continued shift towards subscription models, with agreements signed in 2025 with Circle CVI and mlHealth360, indicating a growing pipeline extending into 2026 [7]. Product Offerings - The company is diversifying its product mix, focusing on data projects and subscription products, including curated bespoke datasets and pre-curated specialty datasets for various therapeutic areas [8]. - Subscription offerings include Palantir Agentic Search for data discovery, which accelerates feasibility analysis from weeks to minutes, and near real-time streaming healthcare data feeds [8]. Strategic Positioning - OneMedNet is entering 2026 with a strong momentum and a high-quality pipeline anchored by premium recurring revenue solutions powered by Palantir Foundry [5]. - The company believes its subscription solutions will drive a more predictable, higher-margin, and scalable revenue profile as it transitions to a predominantly subscription-based business model [9]. Market Demand - There is sustained strong inbound demand for multimodal, regulatory-grade datasets, which serve as foundational entry points into longer-term subscription relationships [14]. - The adoption of AI-enabled discovery workflows is enhancing customer stickiness and creating multiple expansion opportunities within existing accounts [14].

Core Insights - OneMedNet Corporation has achieved significant adoption by a leading global medical device company, recognized for its advancements in diagnostic imaging and digital health solutions [1] - The company has established a master services agreement that allows for ongoing engagement without a fixed term, including multiple purchase orders for Real-World Data [2] - OneMedNet's ability to provide comprehensive, multimodal data sets is emphasized as a key factor in generating Real-World Evidence, which is crucial for AI model development in medical imaging [3] Company Overview - OneMedNet is positioned as a leader in harnessing Real-World Data (RWD) through its iRWD™ platform, which taps into data from over 1,750 healthcare sites [5] - The company focuses on delivering curated, de-identified datasets that empower clients to enhance AI development, clinical trial design, and healthcare outcomes [4] - Beyond healthcare, OneMedNet's proprietary AI technology is applicable in other industries such as finance, retail, and telecom, showcasing its versatility [6]

Core Insights - OneMedNet Corporation has expanded its Cardiovascular network by adding 85 new cardiovascular centers and data sources, positioning itself as one of the largest providers of Cardiovascular Real-World Data (RWD) [1][5] Industry Context - Cardiovascular diseases (CVDs) are the leading cause of death globally, responsible for approximately 19.8 million deaths in 2022, which accounts for about 32% of all global mortality [2] - The economic burden of CVD is significant, driving an estimated $320 billion annually in the United States and over $1 trillion globally in direct healthcare costs and lost productivity [2] Company Positioning - The enriched multimodal cardiovascular data network of OneMedNet is well-suited for the pharmaceutical and insurance sectors, providing real-time data that offers deeper insights into disease progression, treatment responses, and outcomes [3] - The expansion enhances OneMedNet's ability to deliver de-identified cardiovascular imaging, diagnostic reports, and electrocardiograms (ECG) at an unprecedented scale, continually updated to reflect the latest clinical insights [4][6] - OneMedNet is positioned as the premier source for high-quality, regulatory-grade cardiovascular RWD, which fuels innovation, supports clinical evidence generation, and improves patient outcomes [5] Technological Advancements - By combining de-identified cardiovascular imaging, structured reports, and ECG signals, OneMedNet provides real-world clinical insights that accelerate innovation in diagnostics, therapeutics, and AI model development [6] - The company utilizes its iRWD™ platform to harness the potential of over 1,750 healthcare sites, delivering precision insights across various medical fields, including cardiology [7]

Core Insights - OneMedNet Corporation has achieved a greater than 25% expansion of its proprietary iRWD™ network and platform, enhancing its operational capacity and growth trajectory with the addition of over 5 billion administrative records [1][8] - The company is responding to the rising demand for high-quality longitudinal data and insights into health economics and social determinants of health, particularly for underserved populations [2][8] - OneMedNet's iRWD™ network now includes over 1,750 healthcare sites, providing access to 34 million patients and 136 million clinical exams, positioning the company for significant revenue growth through increased data licensing and enterprise partnerships [8] Company Overview - OneMedNet is a leader in AI-powered Real-World Data (RWD), utilizing its iRWD™ platform to harness data from healthcare sites, which fuels innovation in drug development and medical devices [5] - The company emphasizes the importance of clinical integrity in Real-World Evidence, enabling stakeholders in life sciences and healthcare to generate actionable insights reflective of real-world care delivery [4] - The RWE industry is valued at $60 billion, and OneMedNet aims to be at the forefront of this transformation, making evidence generation faster and more effective [4] Market Position - The expansion of OneMedNet's network reinforces its position as a premier data partner, laying the foundation for accelerated revenue generation and customer acquisition [3][8] - The company’s proprietary AI technology anonymizes data for various industries, including finance and retail, showcasing its versatility beyond healthcare [6]